Efficacy of a metallic stent covered with a paclitaxel-incorporated membrane versus a covered metal stent for malignant biliary obstruction: A prospective comparative study

Pharmacology, Toxicology and Pharmaceutical Science

• Chemotherapy 16%
• Cholangitis 4%
• Cholestasis 20%
• Complication 4%
• Diseases 4%
• Gemcitabine 4%
• Human 4%
• In-Stent Restenosis 4%
• Metal 16%
• Neoplasm 8%
• Occlusion 4%
• Paclitaxel 25%
• Pancreatitis 4%
• Stent 100%
• Survival 4%
• Survival Time 8%

Medicine and Dentistry

• Age 4%
• Chemotherapy Regimens 4%
• Cholangitis 4%
• Cholestasis 20%
• Complication 4%
• Conservative Treatment 4%
• Diseases 4%
• Female 4%
• Follow up 4%
• Gemcitabine 4%
• In-Stent Restenosis 4%
• Inpatient 12%
• Male 4%
• Membrane 20%
• Metal 16%
• Neoplasm 8%
• Occlusion 4%
• Paclitaxel 25%
• Pancreatitis 4%
• Patient 29%
• Prognostic Factor 4%
• Self-Expandable Metallic Stent 8%
• Survival 4%
• Survival Time 8%
• Therapeutic Procedure 4%